Intradigm Corporation

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

22 documents for Intradigm Corporation

- Omnia Biologics and Intradigm Sign Deal for Nanomedicine Manufacture.
... drug development company Intradigm Corporation (Intradigm) (Rockville, MD) today announced signin...
- Business Wire
- March 28, 2006
- Intradigm Announces Significant Enhancements of the Company Capabilities, a New Series A Financing and Important Addition to Senior Management Team.
PALO ALTO, Calif. -- Intradigm Corporation, a privately held biotechnology drug development c...
- Business Wire
- November 21, 2006
- New Report Provides Forecasts for the Exciting RNA Interference Market to 2011.
.... Cenix Bioscience GmbH . CytRx Corporation . Dharmacon, Inc. . Integrated DNA Technologies, IInc. (IDT) . Intradigm Corporation . Intronn, Inc. . Invitrogen Corporati...
- Business Wire
- July 13, 2007

- Examine the RNA Interference in the Post-Genomic Era: Markets and Technologies.
...Genable . Genesis . Genecare . Intradigm . Nastech . Nucleonics . Opko Health . Protiva . Q.... BIOGNOSTIK GMBH . BIONEER CORPORATION . BIO-RAD LABORATORIES . CALANDO PHARMACEUTICALS I...
- Business Wire
- November 13, 2008
- SuperGen Names Mohammad Azab, M.D., Chief Medical Officer.
... recently, he was President and CEO of Intradigm Corporation, a privately held Palo Alto, CA compan...
- Business Wire
- July 21, 2009
- Research and Markets: Analyzes the Factors that Influence Market Size and Growth of RNAi Markets.
...Companies mentioned: . - Alfacell Corporation . - Allele Biotechnology and Pharmaceuticals, Inc....- Isis Pharmaceuticals, LLC . - Intradigm Corporation . - Invitrogen . - InvivoGen . - LC Sc...
- Business Wire
- May 21, 2008
- Research and Markets: Delivering RNAi-Based Therapeutics & Diagnostics: Challenges & Opportunities.
...* Expression Genetics Corporation, . * General Research Laboratory . * Intradigm Cor...
- Business Wire
- November 02, 2009
- Tenth Anniversary C21 BioVentures Conference Announces Topical and Informative Program Details.
..., Alvine Pharmaceuticals, AmpliMed Corporation, Anaptys Biosciences, Inc., Antigen Discovery Inco..., GlobeImmune, Inc., Immune Control, Intradigm Corporation, KAI Pharmaceuticals, Inc., Kereos, In...
- Business Wire
- March 18, 2008
- Learn about the World Ophthalmic Pharmaceutical Drugs Market.
... with Bausch & Lomb II-77 Genaera Corporation Quits Evizon Clinical Trials II-77 Eyetech Inc Div... Enters into Agreement with Intradigm Corporation II-86 Apotex Inks Marketing Agreement ...
- Business Wire
- November 25, 2008
- 10th Anniversary C21 BioVentures Conference Provides Partnering, Networking and Financing Opportunities for the Life Sciences.
... Inc, Alvine Pharmaceuticals, AmpliMed Corporation, Anaptys Biosciences, Inc., ApopLogic Pharmaceutic..., GlobeImmune, Inc., Infraredx, Intradigm Corporation, KAI Pharmaceuticals, Inc., Kereos, In...
- Business Wire
- February 27, 2008